Site Survey
Contact Us
Skip links

Association of convalescent plasma therapy with survival in patients with

What The Study Did: Researchers evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic (blood) cancers and COVID-19.

Authors: Jeremy L.Warner, M.D., M.S., of Vanderbilt University in Nashville, Tennessee, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link 


Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.


Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time


JAMA Oncology


Leave a comment